Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease
Mario Cazzola, Francesco Cavalli, Omar S. Usmani, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 5, pp. 635-646
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 10, pp. 3671-3718
Closed Access | Times Cited: 100
Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
Yukun Zhang, Peng Lü, Huan Qin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111072-111072
Open Access | Times Cited: 105
Inhaled drug delivery: Past, present, and future
Ludan Yue, Xueyang Zhang, Chenchen Zhao, et al.
Nano Today (2023) Vol. 52, pp. 101942-101942
Closed Access | Times Cited: 15
Guidance on nebulization during the current COVID-19 pandemic
Mario Cazzola, Josuel Ora, Andrea Bianco, et al.
Respiratory Medicine (2020) Vol. 176, pp. 106236-106236
Open Access | Times Cited: 43
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
Styliani Xiroudaki, Aurélie Schoubben, Stefano Giovagnoli, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1455-1455
Open Access | Times Cited: 35
Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
Gokben Sahin, Özlem Akbal Dağıstan, Meltem Culha, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 10, pp. 2652-2661
Open Access | Times Cited: 25
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
Shohreh Alipour, Laleh Mahmoudi, Fatemeh Ahmadi
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 705-715
Open Access | Times Cited: 23
The Current and Future Role of Technology in Respiratory Care
Persijn Honkoop, Omar S. Usmani, Matteo Bonini
Pulmonary Therapy (2022) Vol. 8, Iss. 2, pp. 167-179
Open Access | Times Cited: 22
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
Maria Gabriella Matera, Nicola A. Hanania, Mauro Maniscalco, et al.
Drugs & Aging (2023) Vol. 40, Iss. 7, pp. 605-619
Open Access | Times Cited: 11
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery
David Encinas-Basurto, Basanth Babu Eedara, Heidi M. Mansour
Journal of Pharmaceutical Investigation (2024) Vol. 54, Iss. 2, pp. 145-160
Closed Access | Times Cited: 3
Emerging trends in pulmonary delivery of biopharmaceuticals
Shalvi Sinai Kunde, Ritushree Ghosh, Sarika Wairkar
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1474-1482
Closed Access | Times Cited: 19
The future of inhalation therapy in chronic obstructive pulmonary disease
Mario Cazzola, Josuel Ora, Luigino Calzetta, et al.
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100092-100092
Open Access | Times Cited: 16
Recent advances predict a bright future for nebulizers
Michael Troy, Joseph Van Vleet, Donald P. Tashkin, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 2, pp. 123-132
Closed Access | Times Cited: 8
Understanding the performance of pressurized metered dose inhalers formulated with low Global warming potential propellants
Hui Wang, J. Sánchez Leal, Mani Ordoubadi, et al.
Aerosol Science and Technology (2024) Vol. 58, Iss. 2, pp. 115-133
Closed Access | Times Cited: 2
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies
Nazrul Islam, Tan Suwandecha, Teerapol Srichana
DARU Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 2
Sex differences in COPD management
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 3, pp. 323-332
Closed Access | Times Cited: 20
Concepts of Advanced Therapeutic Delivery Systems for the Management of Remodeling and Inflammation in Airway Diseases
Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 4, pp. 271-288
Open Access | Times Cited: 13
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia
Gabriella Costabile, Emma Mitidieri, Daniela Visaggio, et al.
International Journal of Pharmaceutics (2022) Vol. 629, pp. 122400-122400
Closed Access | Times Cited: 13
Helical fluid-particle flow dynamics for controlling micron-particle deposition in a representative human upper lung-airway model
Adithya Gurumurthy, Clement Kleinstreuer
Journal of Aerosol Science (2020) Vol. 151, pp. 105656-105656
Closed Access | Times Cited: 20
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
Mario Cazzola, Josuel Ora, Francesco Cavalli, et al.
Biologics (2021) Vol. Volume 15, pp. 363-374
Open Access | Times Cited: 18
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD
Rossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1041-1054
Closed Access | Times Cited: 6
The pharmacological management of asthma in adults: 2023 update
Maria Gabriella Matera, Barbara Rinaldi, Rosa Annibale, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 383-393
Closed Access | Times Cited: 1
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs
Maria Gabriella Matera, Luigino Calzetta, Josuel Ora, et al.
Expert Opinion on Drug Delivery (2021) Vol. 18, Iss. 7, pp. 891-906
Closed Access | Times Cited: 14
Reactive oxygen species modulators in pulmonary medicine
Ankush Sharma, Devesh Tewari, Seyed Fazel Nabavi, et al.
Current Opinion in Pharmacology (2021) Vol. 57, pp. 157-164
Closed Access | Times Cited: 14
Dry powder inhalation, part 2: the present and future
Anne H. de Boer, Paul Hagedoorn, Floris Grasmeijer
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 9, pp. 1045-1059
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top